|
| 34836735 | Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT Analysis. | Clin Oncol (R Coll Radiol) | 2022 |
| 35644708 | Absolute Percentage of Pattern 4 Disease as a Prognostic Measure for Intermediate-risk Prostate Cancer Treated with Stereotactic Body Radiotherapy. | Clin Oncol (R Coll Radiol) | 2022 |
| 33602654 | Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging. | Eur Urol Oncol | 2022 |
| 35050303 | Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts. | JAMA Oncol | 2022 |
| 34400799 | Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trials. | Prostate Cancer Prostatic Dis | 2022 |
| 33035622 | Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control. | Radiother Oncol | 2021 |
| 33637464 | Use and Impact of Positron Emission Tomography/Computed Tomography Prior to Salvage Radiation Therapy in Men with Biochemical Recurrence After Radical Prostatectomy: A Scoping Review. | Eur Urol Oncol | 2021 |
| 34902034 | Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer. | JAMA Netw Open | 2021 |
| 33985797 | Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer. | Eur Urol | 2021 |
| 34196715 | Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features. | JAMA Netw Open | 2021 |
| 32311600 | Prostate bed and organ-at-risk deformation: Prospective volumetric and dosimetric data from a phase II trial of stereotactic body radiotherapy after radical prostatectomy. | Radiother Oncol | 2020 |
| 33293488 | C-MYC Amplification in Chronic Lymphocytic Leukemia: A Case Report and Review of the Literature. | J Assoc Genet Technol | 2020 |
| 32889807 | A Case of t(1;6)(p12;p11.1), Deletion 5q, and Ring 11 in a Patient with Myelodysplastic Syndrome with Excess Blasts Type 1. | J Assoc Genet Technol | 2020 |
| 32889806 | Isochromosome 17q, a Rare Chromosomal Abnormality in a Female Patient with Pancytopenia. | J Assoc Genet Technol | 2020 |
| 32663537 | Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients. | Radiother Oncol | 2020 |
| 31276777 | Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation Therapy. | Int J Radiat Oncol Biol Phys | 2019 |
| 32529134 | Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer. | Adv Radiat Oncol | 2019 |
| 31260486 | Prevalence and correlates of sexually transmitted infections in pregnancy in HIV-infected and- uninfected women in Cape Town, South Africa. | PLoS One | 2019 |
| 28809762 | Elucidation of Novel Chromosomal Abnormalities in Pancreatic Cancer: Conventional and Molecular Cytogenetic Characterization of 16 Pancreatic Cell Lines. | J Assoc Genet Technol | 2017 |
| 28459703 | Novel Cytogenetic Findings in a Case of Mixed Phenotype Acute Leukemia within the Context of a Complex Karyotype. | J Assoc Genet Technol | 2017 |
| 27183380 | A t(17;19)(q22;p13.3) Involving TCF3, a t(1;9)(p13;p13), and a 5' IGH Deletion in a Case of Adult B-cell Acute Lymphoblastic Leukemia. | J Assoc Genet Technol | 2016 |
| 27584682 | An Adult Male Presenting with Concurrent Plasma Cell Myeloma Involving a CCND1-IGH Translocation and Chronic Myelogenous Leukemia with a Variant (9;22) Translocation. | J Assoc Genet Technol | 2016 |
| 27570624 | A novel three-way rearrangement involving ETV6 (12p13) and ABL1 (9q34) with an unknown partner on 3p25 resulting in a possible ETV6-ABL1 fusion in a patient with acute myeloid leukemia: a case report and a review of the literature. | Biomark Res | 2016 |
| 25729575 | A (1;19) translocation involving TCF3-PBX1 fusion within the context of a hyperdiploid karyotype in adult B-ALL: a case report and review of the literature. | Biomark Res | 2015 |
| 26535130 | Erratum to: A case of B-cell acute lymphoblastic leukemia in a child with Down syndrome bearing a t(2;12)(p12;p13) involving ETV6 and biallelic IGH@ rearrangements. | Biomark Res | 2015 |
| 26203356 | A case of B-cell acute lymphoblastic leukemia in a child with Down syndrome bearing a t(2;12)(p12;p13) involving ETV6 and biallelic IGH@ rearrangements. | Biomark Res | 2015 |
| 26030029 | Genes, chromosomes, and disorders of sex development: an update. | J Assoc Genet Technol | 2014 |
| 24274401 | A case of pediatric B-Lymphoblastic leukemia presenting with a t(9;12)(p24;q11.2) involving JAK2 and concomitant MLL rearrangement with apparent insertion at 6q27. | Biomark Res | 2013 |